Moderna, Inc.
Long

MRNA Poised for potential reversal: Key support at $120

140
Moderna (MRNA) stock price shows potential for a reversal near the $120 support level. If the stock remains above this critical support, it is highly likely to reach a target range of $185 to $200 by the end of the year.

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.